Targeting of Cdc42 GTPase in regulatory T cells unleashes antitumor T-cell immunity.
Kalim KW, Yang JQ, Wunderlich M, Modur V, Nguyen P, Li Y, Wen T, Davis AK, Verma R, Lu QR, Jegga AG, Zheng Y, Guo F.
Kalim KW, et al. Among authors: li y.
J Immunother Cancer. 2022 Nov;10(11):e004806. doi: 10.1136/jitc-2022-004806.
J Immunother Cancer. 2022.
PMID: 36427906
Free PMC article.